Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Quantitative cardiovascular magnetic resonance myocardial perfusion can discriminate significant cardiac allograft vasculopathy : a multi-centre study

Jablonowski, R. LU ; Andersson, H. B. ; Fogarasi, C. ; Engblom, H. LU ; Arheden, H. LU ; Kellman, P. LU ; Carlsson, M. LU ; Melin, M. ; Löfman, I. H. and Nickander, J. , et al. (2025) In European Heart Journal Cardiovascular Imaging 26(10). p.1623-1630
Abstract

Aims Cardiac allograft vasculopathy (CAV) is a significant complication that contributes to both morbidity and mortality after heart transplantation. The aim of this study was to (i) assess if quantitative cardiovascular magnetic resonance (CMR) myocardial perfusion could detect different stages of CAV and (ii) establish a myocardial perfusion reserve (MPR) cut-off for significant CAV. Methods and results Patients with a heart transplant who had performed a clinical CMR scan and invasive angiography at two centres in Sweden were included in the study (n = 110). Quantitative short-axis perfusion maps were acquired using single-bolus gadolinium contrast, dual-sequence perfusion imaging at rest and during stress. Global myocardial... (More)

Aims Cardiac allograft vasculopathy (CAV) is a significant complication that contributes to both morbidity and mortality after heart transplantation. The aim of this study was to (i) assess if quantitative cardiovascular magnetic resonance (CMR) myocardial perfusion could detect different stages of CAV and (ii) establish a myocardial perfusion reserve (MPR) cut-off for significant CAV. Methods and results Patients with a heart transplant who had performed a clinical CMR scan and invasive angiography at two centres in Sweden were included in the study (n = 110). Quantitative short-axis perfusion maps were acquired using single-bolus gadolinium contrast, dual-sequence perfusion imaging at rest and during stress. Global myocardial perfusion (MP) was averaged across all segments at rest and stress and MPR was defined as the ratio between stress and rest MP. All invasive angiographies were reported according to the International Heart and Lung Transplantation CAV classification. Patients were classified as follows: 53% (58/110) as CAV0, 38% (42/110) as CAV1, and 9% (10/110) as CAV2–3. There was a gradual decrease of stress MP and MPR with increased CAV grade. The MPR could discriminate CAV2–3 with an area under the curve-receiver operating characteristic of 0.88, 95% confidence interval 0.78–0.98, and using a cut-off of 2.2, the sensitivity was 100%, specificity was 68%, and positive and negative predictive values were 21 and 100%. Conclusion In this multi-centre retrospective study, MPR assessed by CMR could discriminate CAV2–3 with both high sensitivity and negative predictive value and a cut-off of MPR 2.2 is suggested.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
cardiac allograft vasculopathy (CAV), heart transplantation, myocardial perfusion, quantitative cardiovascular magnetic resonance (CMR)
in
European Heart Journal Cardiovascular Imaging
volume
26
issue
10
pages
8 pages
publisher
Oxford University Press
external identifiers
  • scopus:105017554693
  • pmid:40638800
ISSN
2047-2404
DOI
10.1093/ehjci/jeaf201
language
English
LU publication?
yes
id
43ad6809-d405-4652-a142-7f475541347a
date added to LUP
2025-11-26 10:49:18
date last changed
2025-11-26 10:50:16
@article{43ad6809-d405-4652-a142-7f475541347a,
  abstract     = {{<p>Aims Cardiac allograft vasculopathy (CAV) is a significant complication that contributes to both morbidity and mortality after heart transplantation. The aim of this study was to (i) assess if quantitative cardiovascular magnetic resonance (CMR) myocardial perfusion could detect different stages of CAV and (ii) establish a myocardial perfusion reserve (MPR) cut-off for significant CAV. Methods and results Patients with a heart transplant who had performed a clinical CMR scan and invasive angiography at two centres in Sweden were included in the study (n = 110). Quantitative short-axis perfusion maps were acquired using single-bolus gadolinium contrast, dual-sequence perfusion imaging at rest and during stress. Global myocardial perfusion (MP) was averaged across all segments at rest and stress and MPR was defined as the ratio between stress and rest MP. All invasive angiographies were reported according to the International Heart and Lung Transplantation CAV classification. Patients were classified as follows: 53% (58/110) as CAV<sub>0</sub>, 38% (42/110) as CAV<sub>1</sub>, and 9% (10/110) as CAV<sub>2–3</sub>. There was a gradual decrease of stress MP and MPR with increased CAV grade. The MPR could discriminate CAV<sub>2–3</sub> with an area under the curve-receiver operating characteristic of 0.88, 95% confidence interval 0.78–0.98, and using a cut-off of 2.2, the sensitivity was 100%, specificity was 68%, and positive and negative predictive values were 21 and 100%. Conclusion In this multi-centre retrospective study, MPR assessed by CMR could discriminate CAV<sub>2–3</sub> with both high sensitivity and negative predictive value and a cut-off of MPR 2.2 is suggested.</p>}},
  author       = {{Jablonowski, R. and Andersson, H. B. and Fogarasi, C. and Engblom, H. and Arheden, H. and Kellman, P. and Carlsson, M. and Melin, M. and Löfman, I. H. and Nickander, J. and Braun, O.}},
  issn         = {{2047-2404}},
  keywords     = {{cardiac allograft vasculopathy (CAV); heart transplantation; myocardial perfusion; quantitative cardiovascular magnetic resonance (CMR)}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{1623--1630}},
  publisher    = {{Oxford University Press}},
  series       = {{European Heart Journal Cardiovascular Imaging}},
  title        = {{Quantitative cardiovascular magnetic resonance myocardial perfusion can discriminate significant cardiac allograft vasculopathy : a multi-centre study}},
  url          = {{http://dx.doi.org/10.1093/ehjci/jeaf201}},
  doi          = {{10.1093/ehjci/jeaf201}},
  volume       = {{26}},
  year         = {{2025}},
}